Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt
· Delayed Price · Currency is EGP 273.88
+4.57 (1.70%)
At close: Dec 4, 2025
EGX:CPCI Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 4,090 | 2,676 | 997 | 637 | 551 | 539 | Upgrade
|
| Market Cap Growth | 167.91% | 168.26% | 56.67% | 15.47% | 2.38% | 25.17% | Upgrade
|
| Enterprise Value | 4,141 | 2,740 | 1,128 | 710 | 475 | 432 | Upgrade
|
| Last Close Price | 273.88 | 168.55 | 55.89 | 33.04 | 25.22 | 22.22 | Upgrade
|
| PE Ratio | 9.22 | 6.03 | 4.05 | 6.56 | 3.33 | 4.33 | Upgrade
|
| PS Ratio | 1.97 | 1.29 | 0.73 | 0.63 | 0.50 | 0.51 | Upgrade
|
| PB Ratio | 3.91 | 2.56 | 1.20 | 0.94 | 0.69 | 0.77 | Upgrade
|
| P/TBV Ratio | 3.91 | 2.56 | 1.20 | 0.94 | 0.70 | 0.77 | Upgrade
|
| P/FCF Ratio | 17.10 | 11.18 | 21.38 | 67.35 | 15.98 | 3.89 | Upgrade
|
| P/OCF Ratio | 10.80 | 7.07 | 3.79 | 7.19 | 10.64 | 3.32 | Upgrade
|
| EV/Sales Ratio | 1.99 | 1.32 | 0.83 | 0.71 | 0.43 | 0.41 | Upgrade
|
| EV/EBITDA Ratio | 6.86 | 4.57 | 3.88 | 8.04 | 2.29 | 2.76 | Upgrade
|
| EV/EBIT Ratio | 7.29 | 4.83 | 3.95 | 9.26 | 2.47 | 2.76 | Upgrade
|
| EV/FCF Ratio | 17.31 | 11.45 | 24.19 | 75.14 | 13.76 | 3.12 | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.21 | 0.28 | 0.24 | 0.07 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.37 | 0.37 | 0.82 | 1.77 | 0.28 | - | Upgrade
|
| Debt / FCF Ratio | 0.93 | 0.93 | 5.09 | 17.38 | 1.69 | - | Upgrade
|
| Asset Turnover | 1.17 | 1.17 | 0.99 | 0.84 | 0.99 | 1.03 | Upgrade
|
| Inventory Turnover | 2.44 | 2.44 | 1.94 | 2.09 | 2.56 | 2.59 | Upgrade
|
| Quick Ratio | 0.98 | 0.98 | 1.17 | 1.05 | 1.90 | 1.77 | Upgrade
|
| Current Ratio | 1.83 | 1.83 | 2.25 | 2.21 | 3.08 | 2.56 | Upgrade
|
| Return on Equity (ROE) | 47.23% | 47.23% | 32.54% | 13.17% | 22.13% | 18.31% | Upgrade
|
| Return on Assets (ROA) | 20.04% | 20.04% | 12.96% | 3.98% | 10.73% | 9.50% | Upgrade
|
| Return on Capital (ROIC) | 30.36% | 30.36% | 18.65% | 5.65% | 15.43% | 14.39% | Upgrade
|
| Return on Capital Employed (ROCE) | 46.20% | 46.20% | 27.30% | 9.70% | 22.40% | 22.00% | Upgrade
|
| Earnings Yield | 10.85% | 16.58% | 24.67% | 15.25% | 30.06% | 23.08% | Upgrade
|
| FCF Yield | 5.85% | 8.94% | 4.68% | 1.49% | 6.26% | 25.73% | Upgrade
|
| Dividend Yield | 6.11% | 9.93% | 22.95% | 15.13% | 19.83% | 18.00% | Upgrade
|
| Payout Ratio | 49.76% | 49.76% | 34.75% | 103.84% | 45.37% | 62.53% | Upgrade
|
| Total Shareholder Return | 6.11% | 9.93% | 22.95% | 15.13% | 19.83% | 18.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.